DRTS Reports Positive Alpha DaRT Pancreatic Cancer Trial Results, 11.2 Months Median Overall Survival in Metastatic Patients, 36% Treatment-Associated Adverse Events
Alpha Tau Medical Ltd. Ordinary Shares · Now $10.83
-8.0% in 1h after detection
Post-detection moves
1h
-8.0%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS